Condition
Myopic Macular Degeneration
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed1
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05835115Completed
Development and Validation of a Deep Learning-based Myopia and Myopic Maculopathy Detection and Prediction System
NCT03528122Not ApplicableUnknown
Amniotic Membrane for Recurrent Macular Hole
NCT02122159Phase 1WithdrawnPrimary
Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration
Showing all 3 trials